6833.HK
Get informed when a big investor buys or sells
+ Follow| Market cap | $280.54 Million |
|---|---|
| Enterprise Value | $38.52 Million |
| Dividend Yield | $0.00 (1.21%) |
| Earnings per Share | $0.02 |
| Beta | 0.95 |
| Outstanding Shares | 2,032,890,585 |
| P/E Ratio | 7.94 |
|---|---|
| PEG | -43.43 |
| Price to Sales | 0.07 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.01 |
| Enterprise Value to EBIT | 0.24 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 3.31 |
| Debt to Equity | 0.18 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data
Sinco Pharmaceuticals Holdings Limited operates as an investment holding entity primarily specializing in the marketing, promotion, and distribution channel management of imported pharmaceutical products and medical devices throughout Ch...